Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme
Open Access
- 1 July 2020
- journal article
- letter
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 91 (7), 783-785
- https://doi.org/10.1136/jnnp-2020-322938
Abstract
Although symptomatic medicines constitute an important intervention in amyotrophic lateral sclerosis (ALS), few systematic investigations into drug management have been reported so far.1 Furthermore, symptomatic pharmacotherapy is constantly evolving with an increasing number of drugs being used. Therefore, more detailed information on drug prescription must be obtained to monitor the current standards of care, identify potential shortcomings in drug management and elucidate progress in symptomatic pharmacotherapy. Thus, the aims of the present study were to (i) identify the spectrum of symptomatic drugs; (ii) rank symptomatic drugs according to their frequency of use; (iii) assign symptomatic drugs to pharmacological domains and (iv) determine the number of symptomatic drugs per patient. We hypothesised that the pharmacological spectrum and frequency of use range widely. Furthermore, we supposed that symptomatic drug treatment may vary substantially among patients with ALS and may be highly personalised.Funding Information
- Bremer ALS Stiftung
- Boris Canessa ALS Stiftung
- ALS Initiative für Menschen mit ALS
This publication has 7 references indexed in Scilit:
- Provision of assistive technology devices among people with ALS in Germany: a platform-case management approachAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2018
- Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.Drugs & Aging, 2017
- Supportive and symptomatic management of amyotrophic lateral sclerosisNature Reviews Neurology, 2016
- A revision of the El Escorial criteria - 2015Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2015
- The PRO-ACT databaseNeurology, 2014
- Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating ScaleAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2014
- Management of sialorrhoea in motor neuron disease: A survey of current UK practiceAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013